Open Access Open Access  Restricted Access Subscription or Fee Access

Useful Medicinal Operative: Innovative Formulation of Zoloft

Sakshi Sharma

Abstract


A highly effective antidepressant is active metabolite hydrochloride. Zoloft is one of those drugs with one or even more asymmetrical centres where the biological effects of the isomers vary significantly from one another. Depression, dependence, and other anxiety-related illnesses are all treated with sertraline hydrochloride, which selectively blocks serotonine reuptake. The preferred configurations should typically be created as early as feasible in the biosynthesis of sertraline, which has two asymmetric centres, to reduce the loss caused by the undesirable isomer. The physiologically active
1S, 4S-enantiomer of sertraline must be produced with great optical purity since it is one of those medicinal agents with one or more asymmetric centres in which the isomers exhibit substantial change in their biological activity. It is made a straightforward reaction using reagents that are
acceptable in terms of safety and environmental impact from the equivalent tetralone in a high return. Because of the stereoselective nature of its reduction to the necessary cis-racemic amine, sertraline hydrochloride has the required purity for medicinal components. In addition to treating severe cases of premenstrual syndrome, sertraline can also be used to treat mental illness, severe anxiety, panic disorder, post-traumatic stress disorder, and social anxiety disorder (social phobia) (premenstrual dysphoric disorder). Your mood, sleep, appetite, and energy levels may all be enhanced by this
medicine, which may also help you regain interest in regular activities. It might reduce panic attacks as well as fear, anxiety, and unfavourable thoughts. Additionally, it might lessen the need to engage in
repetitive behaviours that interfere with day-to-day functioning (compulsions include hand washing, counting, and checking). Selected serotonin reuptake inhibitor is the name given to sertraline (SSRI). It functions by assisting in the brain's natural chemical, serotonin, to return to equilibrium.


Full Text:

PDF

References


Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19. Clin. Pharmacol. Ther. 2001; 70 (1): 42–7.

doi:10.1067/mcp.2001.116513. PMID 11452243

Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin. Clin. Pharmacol. Ther. 1996; 60

(5): 512–21. doi:10.1016/S0009-9236(96)90147-2. PMID 8941024.

Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K.Sertraline N- demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro". Drug Metab. Dispos. 1999; 27 (7): 763–6. PMID 10383917.

Young TJ, Oliver GP, Pryde D, Perros M, Parkinson T. Antifungal activity of selective serotonin reuptake inhibitors attributed to non-specific cytotoxicity. Journal of Antimicrobial Chemotherapy 2003; 51 (4): 1045–1047. doi:10.1093/jac/dkg184. PMID 12654745.

Gobin V, Van Steendam K, Denys D, Deforce D. Selective serotonin reuptake inhibitors as a novel class of immunosuppressants. Int Immunopharmacol 2014; 20: 148–156.

Ashbury JE, Lévesque LE, Beck PA, Aronson KJ. Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer. Front Oncol 2012; 2: 177.

Pohl RB, Wolkow RM, Clary CM. Sertraline in the treatment of panic disorder: a double-blind multicenter trial. Am J Psychiatr 1998; 155: 1189–1195.

Katzelnick DI, Kobak KA, Greist JH, Jefferson JW, Mantle JM, et al. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatr. 1995; 152: 1368–1371.

Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, et al. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 1995; 10: 57–66.

Ventimiglia J, Kalali AH. Generic penetration in the retail antidepressant market. Psychiatry (Edgmont). 2010; 7: 9–11.


Refbacks

  • There are currently no refbacks.